| Serial Number | 79250188 |
| Word Mark | MEDIGENE |
| Filing Date | Tuesday, July 17, 2018 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, December 17, 2019 |
| Registration Number | 5934628 |
| Registration Date | Tuesday, December 17, 2019 |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, October 1, 2019 |
| Goods and Services | Pharmaceutical and veterinary preparations namely, cellular preparations, T-cell preparations and DC (dendritic cell) preparations for the treatment of cancer and use in immunotherapy; medical compositions for the treatment of hematological and solid tumors, tumor precursors; test kits for diagnostic preparations for medical purposes for determining the type and existence of a tumor in a patient consisting primarily of antibodies, test kits for diagnostic preparations for medical purposes for determining the type and existence of a tumor in a patient consisting primarily of soluble T-cell receptors, test kits for diagnostic preparations for medical purposes for determining the type and existence of a tumor in a patient consisting primarily of genetically modified cells and test kits for diagnostic preparations for medical purposes for determining the type and existence of a tumor in a patient consisting of a composition of antibodies, soluble T-cell receptors and genetically modified cells; diagnostic and therapeutic preparations for medical purposes being mixtures of therapeutically active cells in a suitable medium, in particular produced using molecular biological, biotechnological and genetic methods |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Medical and veterinary medical services, in particular extracting of blood and/or tissue samples and analysis and evaluation relating thereto for medical purposes |
| Goods and Services | Services in molecular biology, namely, research and development in the field of medical and veterinary diagnosis and treatment using molecular biological, biotechnological and genetic methods, and in the field of screening for compounds with pharmaceutical properties; development of test methods and test kits in the field of hematological and solid tumor immunology; biological cell analyses; development of individualized medicine, development of treatment plans and therapy adapted for individual patients; all the foregoing being for scientific and therapeutic purposes; development of adoptive T cell therapy; development of DC vaccines; development of cellular tumour therapy; development of tumour markers; development of diagnostic and therapeutic antibodies; cell analyses; development of individualised medicine, development of treatment plans and therapy adapted for individual patients |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 28, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 28, 2019 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 28, 2019 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Medigene Immunotherapies GmbH |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 27 - NOT AVAILABLE |
| Address | DE |
| Party Name | Medigene Immunotherapies GmbH |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 27 - NOT AVAILABLE |
| Address | DE |
| Party Name | Medigene Immunotherapies GmbH |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 27 - NOT AVAILABLE |
| Address | DE |
| Event Date | Event Description |
| Friday, February 1, 2019 | APPLICATION FILING RECEIPT MAILED |
| Thursday, January 24, 2019 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Monday, January 28, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, January 28, 2019 | ASSIGNED TO EXAMINER |
| Tuesday, February 5, 2019 | NON-FINAL ACTION WRITTEN |
| Wednesday, February 6, 2019 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, February 14, 2019 | REFUSAL PROCESSED BY MPU |
| Thursday, February 14, 2019 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Saturday, March 2, 2019 | REFUSAL PROCESSED BY IB |
| Tuesday, August 13, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, August 13, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, August 13, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, August 22, 2019 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, August 22, 2019 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, August 22, 2019 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, August 22, 2019 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, August 22, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, August 29, 2019 | ASSIGNED TO LIE |
| Wednesday, September 11, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, September 18, 2019 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, September 18, 2019 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Tuesday, October 1, 2019 | PUBLISHED FOR OPPOSITION |
| Tuesday, October 1, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Saturday, October 5, 2019 | NOTIFICATION PROCESSED BY IB |
| Tuesday, December 17, 2019 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, March 17, 2020 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Saturday, March 28, 2020 | FINAL DISPOSITION PROCESSED |
| Saturday, March 28, 2020 | FINAL DISPOSITION NOTICE SENT TO IB |
| Friday, May 1, 2020 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Thursday, August 4, 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Thursday, August 4, 2022 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Thursday, August 4, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, August 4, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, August 4, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, December 17, 2024 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |